Holly Posner

2.1k total citations
22 papers, 984 citations indexed

About

Holly Posner is a scholar working on Psychiatry and Mental health, Neurology and Economics and Econometrics. According to data from OpenAlex, Holly Posner has authored 22 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 6 papers in Neurology and 5 papers in Economics and Econometrics. Recurrent topics in Holly Posner's work include Dementia and Cognitive Impairment Research (12 papers), Neurological Disease Mechanisms and Treatments (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Holly Posner is often cited by papers focused on Dementia and Cognitive Impairment Research (12 papers), Neurological Disease Mechanisms and Treatments (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Holly Posner collaborates with scholars based in United States, United Kingdom and Germany. Holly Posner's co-authors include Yaakov Stern, Margaret Moline, R. Lantigua, R. Mayeux, José A. Luchsinger, Ming Tang, Stephen Salloway, Stefan Cano, Stephen W. Hurt and Hugh S. Markus and has published in prestigious journals such as Neurology, Stroke and The Lancet Neurology.

In The Last Decade

Holly Posner

21 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holly Posner United States 14 557 316 249 161 118 22 984
Gunhild Waldemar Denmark 17 442 0.8× 232 0.7× 229 0.9× 162 1.0× 142 1.2× 29 1.1k
Olga Lucía Pedraza Colombia 9 567 1.0× 158 0.5× 242 1.0× 130 0.8× 184 1.6× 24 1.2k
Ólafur Aevarsson Sweden 13 632 1.1× 247 0.8× 427 1.7× 110 0.7× 64 0.5× 17 1.2k
Anne Börjesson‐Hanson Sweden 22 477 0.9× 204 0.6× 406 1.6× 155 1.0× 89 0.8× 40 1.2k
Marcel Olde‐Rikkert Netherlands 16 368 0.7× 121 0.4× 286 1.1× 126 0.8× 65 0.6× 28 1.2k
Neda Minakaran United Kingdom 7 378 0.7× 224 0.7× 326 1.3× 122 0.8× 97 0.8× 19 1.1k
Soichiro Shimizu Japan 23 567 1.0× 249 0.8× 560 2.2× 328 2.0× 263 2.2× 86 1.4k
Vincent Chouraki France 10 548 1.0× 182 0.6× 475 1.9× 74 0.5× 62 0.5× 20 1.4k
Carina Wattmo Sweden 22 704 1.3× 160 0.5× 473 1.9× 96 0.6× 141 1.2× 44 1.2k
Lieza G. Exalto Netherlands 14 442 0.8× 235 0.7× 267 1.1× 95 0.6× 65 0.6× 39 987

Countries citing papers authored by Holly Posner

Since Specialization
Citations

This map shows the geographic impact of Holly Posner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Posner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Posner more than expected).

Fields of papers citing papers by Holly Posner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Posner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Posner. The network helps show where Holly Posner may publish in the future.

Co-authorship network of co-authors of Holly Posner

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Posner. A scholar is included among the top collaborators of Holly Posner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Posner. Holly Posner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderson, Samira, Guido Cavaletti, Linda J. Hood, et al.. (2024). A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata. Pharmacology Research & Perspectives. 12(4). e1204–e1204. 4 indexed citations
2.
Posner, Holly, Rosie E. Curiel, Chris J. Edgar, et al.. (2017). Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs.. PubMed. 14(1-2). 22–29. 43 indexed citations
3.
Harvey, Philip D., Stephanie Cosentino, Rosie E. Curiel, et al.. (2017). Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer's Disease Spectrum.. PubMed. 14(1-2). 30–39. 25 indexed citations
4.
French, Jacqueline A., Paul Glue, Daniel Friedman, et al.. (2016). Adjunctive pregabalin vs gabapentin for focal seizures. Neurology. 87(12). 1242–1249. 17 indexed citations
5.
French, Jacqueline A., Christian Brandt, Daniel Friedman, et al.. (2014). Adjunctive use of controlled‐release pregabalin in adults with treatment‐resistant partial seizures: A double‐blind, randomized, placebo‐controlled trial. Epilepsia. 55(8). 1220–1228. 27 indexed citations
6.
Zaccara, Gaetano, Mary Almas, Verne Pitman, Lloyd Knapp, & Holly Posner. (2014). Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: A randomized, double‐blind, noninferiority trial. Epilepsia. 55(7). 1048–1057. 21 indexed citations
7.
Posner, Holly, Stefan Cano, María C. Carrillo, et al.. (2013). Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: A new approach. Alzheimer s & Dementia. 9(1S). S56–60. 9 indexed citations
8.
Hobart, Jeremy, Stefan Cano, Holly Posner, et al.. (2012). Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory. Alzheimer s & Dementia. 9(1S). S10–20. 46 indexed citations
9.
Logue, Mark W., Holly Posner, Richard C. Green, et al.. (2011). Magnetic resonance imaging‐measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients. Alzheimer s & Dementia. 7(5). 493–500. 13 indexed citations
10.
Cano, Stefan, Holly Posner, Margaret Moline, et al.. (2010). The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts. Journal of Neurology Neurosurgery & Psychiatry. 81(12). 1363–1368. 143 indexed citations
11.
Black, Ronald S., Barry Greenberg, J. Michael Ryan, et al.. (2009). Scales as outcome measures for Alzheimer's disease. Alzheimer s & Dementia. 5(4). 324–339. 32 indexed citations
12.
Cano, Stefan, Holly Posner, Paul Aisen, et al.. (2009). O4‐04‐07: The ADAS‐cog's performance as a measure—lessons from the ADNI study: Part 2 ‐ evaluation using modern psychometric methods. Alzheimer s & Dementia. 5(4S_Part_5).
13.
Wilkinson, David, Gustavo C. Román, Stephen Salloway, et al.. (2009). The long‐term efficacy and tolerability of donepezil in patients with vascular dementia. International Journal of Geriatric Psychiatry. 25(3). 305–313. 18 indexed citations
14.
Hobart, Jeremy, Holly Posner, Paul Aisen, et al.. (2009). P1‐270: The ADAS‐cog's performance as a measure ‐ lessons from the ADNI study: Part 3 ‐ do the scale modifications add value?. Alzheimer s & Dementia. 5(4S_Part_9). 6 indexed citations
15.
Dichgans, Martin, Hugh S. Markus, Stephen Salloway, et al.. (2008). Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. The Lancet Neurology. 7(4). 310–318. 164 indexed citations
16.
Guermazi, Ali, et al.. (2006). Neuroradiological findings in vascular dementia. Neuroradiology. 49(1). 1–22. 32 indexed citations
17.
Román, Gustavo C., et al.. (2006). P.5.a.011 Efficacy and safety of donepezil in vascular dementia:results from the largest double-blind trial in vascular dementia patients. European Neuropsychopharmacology. 16. S481–S482. 1 indexed citations
18.
Doody, Rachelle S., Raymond Pratt, Holly Posner, & Dinesh Kumar. (2004). P3-402 Vascular dementia patients who receive donepezil treatment for 12 to 18 months maintain cognitive benefits. Neurobiology of Aging. 25. S469–S470. 2 indexed citations
19.
Posner, Holly, Ming Tang, José A. Luchsinger, et al.. (2002). The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology. 58(8). 1175–1181. 237 indexed citations
20.
Posner, Holly, Steven S. Chin, & Karen Marder. (2001). Dementia with Lewy Bodies. Science of Aging Knowledge Environment. 2001(3). dn3–dn3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gunhild Waldemar Breakdown of academic impact, for papers by Olga Lucía Pedraza Breakdown of academic impact, for papers by Ólafur Aevarsson Breakdown of academic impact, for papers by Anne Börjesson‐Hanson Breakdown of academic impact, for papers by Marcel Olde‐Rikkert Breakdown of academic impact, for papers by Neda Minakaran Breakdown of academic impact, for papers by Soichiro Shimizu Breakdown of academic impact, for papers by Vincent Chouraki Breakdown of academic impact, for papers by Carina Wattmo Breakdown of academic impact, for papers by Lieza G. Exalto
Rankless by CCL
2026